Visible-to-NIR-light activated release: from small molecules to nanomaterials

R Weinstain, T Slanina, D Kand, P Klan - Chemical reviews, 2020‏ - ACS Publications
Photoactivatable (alternatively, photoremovable, photoreleasable, or photocleavable)
protecting groups (PPGs), also known as caged or photocaged compounds, are used to …

Therapeutic nanoparticles and their targeted delivery applications

AA Yetisgin, S Cetinel, M Zuvin, A Kosar, O Kutlu - Molecules, 2020‏ - mdpi.com
Nanotechnology offers many advantages in various fields of science. In this regard,
nanoparticles are the essential building blocks of nanotechnology. Recent advances in …

Application of nanomaterials in biomedical imaging and cancer therapy

S Siddique, JCL Chow - Nanomaterials, 2020‏ - mdpi.com
Nanomaterials, such as nanoparticles, nanorods, nanosphere, nanoshells, and nanostars,
are very commonly used in biomedical imaging and cancer therapy. They make excellent …

Functional supramolecular systems: Design and applications

IS Antipin, MV Alfimov, VV Arslanov… - Russian Chemical …, 2021‏ - iopscience.iop.org
The interest in functional supramolecular systems for the design of innovative materials and
technologies, able to fundamentally change the world, is growing at a high pace. The huge …

A review on the green and sustainable synthesis of silver nanoparticles and one-dimensional silver nanostructures

S Kaabipour, S Hemmati - Beilstein Journal of …, 2021‏ - beilstein-journals.org
The significance of silver nanostructures has been growing considerably, thanks to their
ubiquitous presence in numerous applications, including but not limited to renewable …

Mesoporous silica nanoparticles as delivery carriers: An overview of drug loading techniques

KB Seljak, P Kocbek, M Gašperlin - Journal of Drug Delivery Science and …, 2020‏ - Elsevier
Mesoporous silica nanoparticles (MSNs) are arising as a promising delivery system for a
more effective and safer therapy of many diseases, such as cancer, osteoporosis and …

Clinical therapies and nano drug delivery systems for urinary bladder cancer

P Jain, H Kathuria, M Momin - Pharmacology & Therapeutics, 2021‏ - Elsevier
Bladder cancer is the 10 th most commonly occurring malignancy worldwide with a 75% of 5-
year survival rate, while it ranks 13 th among the deaths occurring due to cancer. The …

Selected strategies to fight pathogenic bacteria

A Plotniece, A Sobolev, CT Supuran… - Journal of enzyme …, 2023‏ - Taylor & Francis
Natural products and analogues are a source of antibacterial drug discovery. Considering
drug resistance levels emerging for antibiotics, identification of bacterial metalloenzymes …

Approved and marketed nanoparticles for disease targeting and applications in COVID-19

AAH Abdellatif, AF Alsowinea - Nanotechnology Reviews, 2021‏ - degruyter.com
Nano-based systems can be used to transport active medicinal products to specific parts of
the body. Most challenges with drug delivery, such as low water solubility and poor …

Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses

DJH Tng, JGH Low - Antiviral Research, 2023‏ - Elsevier
In the past decade, interest in nanoparticles for clinical indications has been steadily gaining
traction. Most recently, Lipid Nanoparticles (LNP) have been used successfully to construct …